RESULTS

Supplementary
One liver transplant patient who died was excluded from the mortality analysis because death was unrelated to CMV.
Supplementary Figure 1. ROC curves for predicting severe CMV disease in (A) renal and (B) liver transplant patients using CMV viral load AUC and Vmax.
Evaluating viral load as a marker of morbidity To investigate the potential utility of viral load AUC or Vmax as a predictor of severe disease status in renal or liver transplant patients, receiver operating characteristic (ROC) curves were constructed predicting severe CMV disease versus absent-to-moderate CMV disease. These curves and their corresponding AUROCs are shown in Supplementary Figure 1 . The AUROCs for predicting severe CMV disease versus absent-to-moderate CMV disease using viral load AUC were 0.776 and 0.895 for renal and liver transplant patients, respectively, and 0.792 and 0.893 for predicting severe CMV disease using viral load Vmax. AUROCs are higher for liver transplant patients relative to renal transplant patients due to the lack of mildly diseased liver transplant patients (Supplementary Table 1) , which resulted in a smaller overlap between the disease classes in the liver transplant patients. 
